Skip to main content
Signal8

Drugs Made In America Acquisition II Corp. (DMII)

Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.

Sector: Blank Checks

Industry: Financial - Conglomerates

Drugs Made In America Acquisition II Corp. Ordinary Shares logo

Drugs Made In America Acquisition II Corp. Ordinary Shares

NASDAQ:DMIIFinancial Services
+0.00%$10.19
AH Close$10.19+0.00%vs close
Mkt Cap$649.1M
Float60.34M
O/S63.7M
Inst Own71.4%
SI0.2%
Dilution
Drugs Made In America Acquisition II Corp. Ordinary Shares logoNASDAQ:DMII$10.19+0.00%
FormDescription
10-Q
10-Q
8-K
CURRENT REPORT
10-K
ANNUAL REPORT
8-K
CURRENT REPORT
NT 10-K
NOTIFICATION OF LATE FILING
8-K
CURRENT REPORT
8-K
8.01
8-K
CURRENT REPORT
10-Q
QUARTERLY REPORT
8-K
CURRENT REPORT
NT 10-Q
NOTIFICATION OF LATE FILING
4
Statement of Changes in Beneficial Ownership
8-K
CURRENT REPORT
4
Statement of Changes in Beneficial Ownership
13D
Beneficial Ownership Report (Active)
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
CURRENT REPORT
3
Initial Statement of Beneficial Ownership
424B4
PROSPECTUS SUPPLEMENT
EFFECT
Notice of Effectiveness
3
Initial Statement of Beneficial Ownership

1-25 of 45